Inotiv, Inc. (NOTV)
USD 1.65
(-0.3%)
USD 1.65
(-0.3%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -4.10 USD | 70.4% |
| 2022 | -13.85 USD | -1768.67% |
| 2021 | 0.83 USD | 293.02% |
| 2020 | -0.43 USD | -465.05% |
| 2019 | -0.08 USD | -244.34% |
| 2018 | -0.02 USD | -120.09% |
| 2017 | 0.11 USD | 127.5% |
| 2016 | -0.40 USD | -385.71% |
| 2015 | 0.14 USD | 207.69% |
| 2014 | -0.13 USD | -230.0% |
| 2013 | 0.10 USD | 111.24% |
| 2012 | -0.89 USD | -20.27% |
| 2011 | -0.74 USD | -34.55% |
| 2010 | -0.55 USD | 50.45% |
| 2009 | -1.11 USD | -270.0% |
| 2008 | -0.30 USD | -257.89% |
| 2007 | 0.19 USD | 135.85% |
| 2006 | -0.53 USD | -2460.39% |
| 2005 | -0.02 USD | 50.48% |
| 2004 | -0.04 USD | -518.0% |
| 2003 | 0.01 USD | -95.65% |
| 2002 | 0.23 USD | -41.03% |
| 2001 | 0.39 USD | 230.0% |
| 2000 | -0.30 USD | -330.77% |
| 1999 | 0.13 USD | 30.0% |
| 1998 | 0.10 USD | -66.67% |
| 1997 | 0.30 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -1.86 USD | -210.0% |
| 2024 Q3 | -1.00 USD | 46.24% |
| 2024 Q1 | -0.60 USD | -57.89% |
| 2023 Q2 | -0.37 USD | 89.12% |
| 2023 Q3 | 0.07 USD | 119.32% |
| 2023 Q4 | -0.38 USD | -631.47% |
| 2023 Q1 | -3.40 USD | 64.29% |
| 2023 FY | - USD | 70.4% |
| 2022 Q3 | -0.15 USD | 42.31% |
| 2022 Q1 | -3.95 USD | -769.49% |
| 2022 Q2 | -0.26 USD | 93.42% |
| 2022 FY | - USD | -1768.67% |
| 2022 Q4 | -9.52 USD | -6246.67% |
| 2021 Q1 | -0.03 USD | 79.25% |
| 2021 Q3 | -0.15 USD | -131.48% |
| 2021 FY | - USD | 293.02% |
| 2021 Q4 | 0.59 USD | 493.33% |
| 2021 Q2 | -0.06 USD | -95.18% |
| 2020 Q1 | -0.13 USD | -533.33% |
| 2020 Q4 | -0.16 USD | -98.51% |
| 2020 Q3 | -0.08 USD | -48.71% |
| 2020 FY | - USD | -465.05% |
| 2020 Q2 | -0.05 USD | 58.31% |
| 2019 Q1 | -0.01 USD | 57.65% |
| 2019 Q4 | 0.03 USD | 173.89% |
| 2019 FY | - USD | -244.34% |
| 2019 Q3 | -0.04 USD | 26.58% |
| 2019 Q2 | -0.06 USD | -566.27% |
| 2018 Q3 | -0.01 USD | -191.0% |
| 2018 Q1 | 0.00 USD | -89.33% |
| 2018 FY | - USD | -120.09% |
| 2018 Q4 | -0.02 USD | -115.38% |
| 2018 Q2 | 0.01 USD | 212.5% |
| 2017 Q3 | 0.03 USD | -40.0% |
| 2017 Q1 | 0.00 USD | 100.84% |
| 2017 FY | - USD | 127.5% |
| 2017 Q2 | 0.05 USD | 2280.95% |
| 2017 Q4 | 0.03 USD | 0.0% |
| 2016 FY | - USD | -385.71% |
| 2016 Q2 | -0.03 USD | 49.84% |
| 2016 Q1 | -0.06 USD | 29.89% |
| 2016 Q3 | -0.05 USD | -70.61% |
| 2016 Q4 | -0.25 USD | -368.16% |
| 2015 Q1 | 0.02 USD | 140.0% |
| 2015 Q2 | 0.02 USD | 0.0% |
| 2015 Q3 | 0.18 USD | 800.0% |
| 2015 Q4 | -0.09 USD | -149.44% |
| 2015 FY | - USD | 207.69% |
| 2014 FY | - USD | -230.0% |
| 2014 Q4 | -0.05 USD | -266.67% |
| 2014 Q3 | 0.03 USD | 209.09% |
| 2014 Q2 | -0.03 USD | 69.44% |
| 2014 Q1 | -0.09 USD | -400.0% |
| 2013 FY | - USD | 111.24% |
| 2013 Q4 | 0.03 USD | -62.5% |
| 2013 Q3 | 0.08 USD | 461.99% |
| 2013 Q2 | -0.02 USD | -173.67% |
| 2013 Q1 | 0.03 USD | 109.68% |
| 2012 Q1 | -0.21 USD | -117.84% |
| 2012 Q3 | -0.10 USD | 64.07% |
| 2012 FY | - USD | -20.27% |
| 2012 Q2 | -0.27 USD | -28.57% |
| 2012 Q4 | -0.31 USD | -219.59% |
| 2011 Q2 | 0.10 USD | 66.67% |
| 2011 Q4 | -0.10 USD | 85.17% |
| 2011 Q1 | 0.06 USD | 205.26% |
| 2011 FY | - USD | -34.55% |
| 2011 Q3 | -0.65 USD | -750.0% |
| 2010 Q1 | -0.30 USD | -3.45% |
| 2010 Q2 | -0.25 USD | 16.67% |
| 2010 Q3 | 0.06 USD | 124.0% |
| 2010 FY | - USD | 50.45% |
| 2010 Q4 | -0.06 USD | -195.0% |
| 2009 Q4 | -0.29 USD | -123.08% |
| 2009 FY | - USD | -270.0% |
| 2009 Q1 | -0.32 USD | -45.45% |
| 2009 Q2 | -0.37 USD | -15.63% |
| 2009 Q3 | -0.13 USD | 64.86% |
| 2008 Q3 | -0.05 USD | -86.64% |
| 2008 Q4 | -0.22 USD | -325.53% |
| 2008 Q1 | -0.00 USD | 92.01% |
| 2008 Q2 | -0.03 USD | -739.39% |
| 2008 FY | - USD | -257.89% |
| 2007 Q2 | 0.03 USD | -72.73% |
| 2007 Q4 | -0.04 USD | -145.89% |
| 2007 Q3 | 0.09 USD | 200.0% |
| 2007 FY | - USD | 135.85% |
| 2007 Q1 | 0.11 USD | 173.33% |
| 2006 Q1 | -0.15 USD | -2127.03% |
| 2006 Q2 | 0.11 USD | 173.33% |
| 2006 Q3 | -0.34 USD | -409.09% |
| 2006 Q4 | -0.15 USD | 55.88% |
| 2006 FY | - USD | -2460.39% |
| 2005 Q1 | 0.08 USD | 290.02% |
| 2005 Q2 | -0.18 USD | -325.0% |
| 2005 Q3 | 0.07 USD | 138.89% |
| 2005 Q4 | 0.01 USD | -89.43% |
| 2005 FY | - USD | 50.48% |
| 2004 Q3 | 0.13 USD | 230.0% |
| 2004 Q1 | -0.03 USD | 65.29% |
| 2004 FY | - USD | -518.0% |
| 2004 Q4 | -0.04 USD | -132.38% |
| 2004 Q2 | -0.10 USD | -271.75% |
| 2003 Q2 | -0.04 USD | -160.5% |
| 2003 Q1 | 0.06 USD | 1328.57% |
| 2003 FY | - USD | -95.65% |
| 2003 Q4 | -0.08 USD | -196.88% |
| 2003 Q3 | 0.08 USD | 320.39% |
| 2002 Q3 | 0.06 USD | -45.45% |
| 2002 Q4 | 0.00 USD | -93.0% |
| 2002 FY | - USD | -41.03% |
| 2002 Q2 | 0.11 USD | 120.0% |
| 2002 Q1 | 0.05 USD | -50.0% |
| 2001 Q4 | 0.10 USD | -9.09% |
| 2001 FY | - USD | 230.0% |
| 2001 Q3 | 0.11 USD | -15.38% |
| 2001 Q2 | 0.13 USD | 225.0% |
| 2001 Q1 | 0.04 USD | 141.11% |
| 2000 Q4 | -0.10 USD | -219.02% |
| 2000 Q2 | -0.09 USD | -5.64% |
| 2000 Q1 | -0.09 USD | -233.43% |
| 2000 Q3 | -0.03 USD | 67.41% |
| 2000 FY | - USD | -330.77% |
| 1999 Q3 | 0.01 USD | -75.0% |
| 1999 Q2 | 0.04 USD | 0.0% |
| 1999 Q1 | - USD | 100.0% |
| 1999 FY | - USD | 30.0% |
| 1999 Q4 | 0.07 USD | 564.0% |
| 1998 Q4 | -0.04 USD | -248.0% |
| 1998 Q1 | 0.06 USD | 1968.97% |
| 1998 Q2 | 0.05 USD | -16.67% |
| 1998 FY | - USD | -66.67% |
| 1998 Q3 | 0.03 USD | -40.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q4 | 0.00 USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -1.27 USD | -222.835% |
| Applied DNA Sciences, Inc. | -15.21 USD | 73.044% |
| Aspira Women's Health Inc. | -1.81 USD | -126.519% |
| Biodesix, Inc. | -0.64 USD | -540.625% |
| BioNexus Gene Lab Corp. | -0.17 USD | -2311.765% |
| bioAffinity Technologies, Inc. | -0.91 USD | -350.549% |
| bioAffinity Technologies, Inc. | -0.91 USD | -350.549% |
| Bionano Genomics, Inc. | -6.81 USD | 39.794% |
| CareDx, Inc | -3.54 USD | -15.819% |
| Check-Cap Ltd. | -3.00 USD | -36.667% |
| Castle Biosciences, Inc. | -2.14 USD | -91.589% |
| DarioHealth Corp. | -1.93 USD | -112.435% |
| Exact Sciences Corporation | -1.13 USD | -262.832% |
| Fulgent Genetics, Inc. | -5.63 USD | 27.176% |
| Guardant Health, Inc. | -4.28 USD | 4.206% |
| ICON Public Limited Company | 7.46 USD | 154.96% |
| IDEXX Laboratories, Inc. | 10.17 USD | 140.315% |
| Illumina, Inc. | -7.35 USD | 44.218% |
| Intelligent Bio Solutions Inc. | -6.38 USD | 35.737% |
| iSpecimen Inc. | -1.23 USD | -233.333% |
| Standard BioTools Inc. | -0.94 USD | -336.17% |
| MDxHealth SA | -1.66 USD | -146.988% |
| 23andMe Holding Co. | -1.40 USD | -192.857% |
| Medpace Holdings, Inc. | 9.20 USD | 144.565% |
| Myriad Genetics, Inc. | -1.39 USD | -194.964% |
| Mainz Biomed B.V. | -1.62 USD | -153.086% |
| ENDRA Life Sciences Inc. | -1.11 USD | -269.369% |
| NeoGenomics, Inc. | -0.70 USD | -485.714% |
| Neogen Corporation | -0.04 USD | -9325.287% |
| Natera, Inc. | -3.78 USD | -8.466% |
| OpGen, Inc. | -41.47 USD | 90.113% |
| OPKO Health, Inc. | -0.25 USD | -1540.0% |
| Psychemedics Corporation | -0.72 USD | -469.444% |
| Prenetics Global Limited | -5.58 USD | 26.523% |
| Prenetics Global Limited | -5.58 USD | 26.523% |
| Precipio, Inc. | -4.51 USD | 9.091% |
| Personalis, Inc. | -2.25 USD | -82.222% |
| RadNet, Inc. | 0.05 USD | 8659.499% |
| Sera Prognostics, Inc. | -1.16 USD | -253.448% |
| Sotera Health Company | 0.18 USD | 2377.778% |
| Neuronetics, Inc. | -1.05 USD | -290.476% |
| Star Equity Holdings, Inc. | 7.42 USD | 155.256% |
| Star Equity Holdings, Inc. | 7.42 USD | 155.256% |
| Trinity Biotech plc | -3.14 USD | -30.573% |
| T2 Biosystems, Inc. | -19.19 USD | 78.635% |
| Twist Bioscience Corporation | -3.60 USD | -13.889% |
| Exagen Inc. | -1.34 USD | -205.97% |